MEIP: Rata-rata rega prakiraan MEI Pharma Inc

Simbol lan logo merek MEI Pharma Inc (MEIP)

The daily price action for MEI Pharma, Inc. (MEIP) shown on this chart reflects a current value of 22.61. The business relies on its scientific authority gained through the development of cutting-edge methods for combating hematologic malignancies. However, the organization is currently undergoing a wind-down and shareholder payout phase following failed trials, as confirmed by the SEC. Global conflicts further complicate the situation, hindering raw material logistics and patent protection.

MEI Pharma Corporation (MEIP): Bagan rega target saka 04.07.2022 nganti 11.09.2025

Rincian analitis perusahaan MEI Pharma Corp (MEIP)

Indikator analitis utama MEI Pharma Corporation (MEIP):
Kutipan saham meipharma.com|MEIP - Prakiraan konsensus analis|Nilai pasar MEI Pharma Corp
Analisis fundamental perusahaan:meipharma.com (MEIP)
Produk asli MEI Pharma Corp

The colossal scaling potential of MEI Pharma, Inc. (MEIP) in hematologic oncology directly drives changes in the consensus valuation of the stock, reflecting market expectations for the global rollout of its drugs. This indicator represents an aggregated discounted cash flow model, where analysts continuously recalculate the cost of capital to determine the fair market value of the company's assets.

Perusahaan pesaing

Target konsensus tgtherapeutics.com TGTX|Prakiraan konsensus analis ACLX (Arcellx, Inc.)|Disc Medicine Inc (IRON) - Rata-rata rega prakiraan|Syndax - Prakiraan konsensus analis|Target median analis Kura KURA|ADC Therapeutics (ADCT) - Bagan rega target|Bagan tingkat prakiraan FHTX (Foghorn Therapeutics Inc.)|VOR (Vor Biopharma) - Prakiraan konsensus analis|Target konsensus Nkarta Corp (NKTX)|Prakiraan konsensus analis COEP|Prakiraan konsensus analis Actinium Corp (ATNM)|Bagan rega target Estrella Immunopharma ESLA|CASI: Prakiraan gabungan firma investasi|Marker Bio - Prakiraan konsensus analis|IN8bio Inc. (INAB) - Target konsensus|ERNA: Prakiraan konsensus analis|Rata-rata rega prakiraan GT Biopharma Corporation (GTBP)|Bagan rega target Aptose Biosciences Inc|BPTH: Konsensus nilai wajar|Target konsensus VINC (Vincerx Pharma, Inc.)